about
Coverage of atypical antipsychotics among medicare drug plans in the state of washington: changes between 2007 and 2008.Assessing medication adherence and healthcare utilization and cost patterns among hospital-discharged patients with schizoaffective disorder.Trend and pattern of herb and supplement use in the United States: results from the 2002, 2007, and 2012 national health interview surveysFluoroquinolones versus β-Lactam/β-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based StudyComparative Outcome Analysis of Penicillin-Based Versus Fluoroquinolone-Based Antibiotic Therapy for Community-Acquired Pneumonia: A Nationwide Population-Based Cohort StudyAntidepressants and Valvular Heart Disease: A Nested Case-Control Study in Taiwan.Patterns and predictors of antipsychotic medication use among the U.S. population: findings from the Medical Expenditure Panel Survey.The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.Patterns of Pharmacological Treatment for Osteoporosis Among Patients Qualified for Pharmacotherapy According to the National Osteoporosis Foundation Guidelines.Alternative Therapies as a Substitute for Costly Prescription Medications: Results from the 2011 National Health Interview Survey.Trends in energy and macronutrient intakes by weight status over four decades.Treatment patterns, complications, and disease relapse in a real-world population of patients with moderate-to-severe ulcerative colitis initiating immunomodulator therapy.Reimbursement changes and drug switching: are severe patients more affected?Changes in herb and dietary supplement use in the U.S. adult population: a comparison of the 2002 and 2007 National Health Interview Surveys.Cost-effectiveness of the pharmacist-assisted warfarin monitoring program at a Medical Center in Taiwan.Effectiveness and Safety of Different Rivaroxaban Dosage Regimens in Patients with Non-Valvular Atrial Fibrillation: A Nationwide, Population-Based Cohort Study.National trends of psychotropic medication use among patients diagnosed with anxiety disorders: results from medical expenditure panel survey 2004-2009Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with ProteinuriaA Web-Based Clinical System for Cohort Surveillance of Specific Clinical Effectiveness and Safety Outcomes: A Cohort Study of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin
P50
Q33587010-EE24E985-6ABD-4006-9E12-C43A49FBF406Q33633758-7C57E8AB-B471-4046-AB2E-D8B6F59A1FC4Q34773889-7C633B5B-60A2-4D39-B8AC-B020EFC28C57Q35754952-ADE50800-C76C-4E70-A4F8-D2AD421163F7Q36581089-49AE5176-AA72-46AC-B563-BECB1D557F6FQ37206591-8D6F24CC-070E-4B5E-8E8E-873E550AAE14Q37832802-5B9EB654-9DA4-4DE8-88B0-188E6493B8A3Q40790714-482F713B-972E-46F6-8FB7-B422C4F4C77CQ40871023-BE7961D2-31D3-487D-BD90-8C93536451C7Q41275461-021FEF36-10A8-4CBB-86CD-B0BE6FDEDFB2Q45790751-2A7E24A0-87E7-48D0-BA3C-B3ADE610C6B2Q46956322-D9F7DD63-8C22-4BD5-AC21-17A9F3E34DADQ47877693-B3E69C26-D4A8-4F9C-901B-F7D5811C30F7Q48565707-F067ED49-3877-4C11-B7EB-F01DCC922B2AQ50100179-6A6FC4F4-CE88-4C7E-A4DC-FD29BCBC1A32Q55258970-91166C88-F98F-444F-AC7F-63E187F61FDEQ86179357-499998B6-711E-4873-86E7-5F4D9E35F6ECQ88320190-812B59A8-734E-4E9D-ADD7-0919B0EAAAC1Q91601311-21A4D509-4FBA-4392-9ABB-A8638C645B83
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Chi-Chuan Wang
@ast
Chi-Chuan Wang
@en
Chi-Chuan Wang
@es
Chi-Chuan Wang
@nl
type
label
Chi-Chuan Wang
@ast
Chi-Chuan Wang
@en
Chi-Chuan Wang
@es
Chi-Chuan Wang
@nl
prefLabel
Chi-Chuan Wang
@ast
Chi-Chuan Wang
@en
Chi-Chuan Wang
@es
Chi-Chuan Wang
@nl
P106
P1153
24554487300
P31
P496
0000-0002-4597-4859